Video
Virtual Investor Conferences
Watch the Abingdon Health plc (OTCQB: ABDXF | LSE: ABDX) presentation from the June 24th & 25th Life Sciences Virtual…
Three specialist divisions working together to take your product from early concept through development, regulation and manufacture to market.
From initial concept to commercial product, our divisions cover every stage of the diagnostic and device lifecycle.
From lateral flow and ELISA to clinical trials and contract manufacturing, we develop, validate and produce rapid diagnostic tests at scale.
Explore Diagnostics →
Accredited laboratory services supporting your product through development and post-market, from shelf life to method validation.
Explore Analytical →
Expert guidance on CE/UKCA marking, IVDR compliance and quality management systems for IVDs and medical devices.
Explore AI & MedTech →
Abingdon Health is a global developer, manufacturer and regulatory services provider specialising in lateral flow technology. Operating as both a CRO and CDMO, we offer an integrated service that takes your product from concept to commercialisation.
We are passionate about improving life by making rapid results accessible to all. Our promise is simple: working together with integrity, building long-lasting, transparent partnerships with our customers, technology partners and colleagues.
Our ambition is to deliver real-world positive change by being a leading provider of global MedTech CDMO, CRO and regulatory services, bridging the gap between diagnostic and device innovation and real-world impact.
Fast-tracking diagnostics and devices to improve lives
We are committed and honest in all that we do. We value quality and the contribution of all, and pride ourselves on building trust-based partnerships.
A closer look at how our three divisions have taken client programmes from early concept to commercial reality.
News, case studies and technical resources from across our three divisions.
Video
Watch the Abingdon Health plc (OTCQB: ABDXF | LSE: ABDX) presentation from the June 24th & 25th Life Sciences Virtual…
News
York, U.K. – 13 October 2026: Abingdon Health plc (AIM: ABDX) (OTCQB: ABDXF), a leading international developer, manufacturer and regulatory…
AI & MedTech
Guide
Regulatory, quality and clinical support for medical devices, SaMD and AI-enabled products across the US, EU, UK and 90+ territories.
With facilities across the UK and the United States, we support clients worldwide.
Group headquarters, manufacturing and development. Home to our clean room production facilities and core R&D operations.
UKAS-accredited analytical laboratory providing stability studies, method validation and regulatory testing services.
US operations and client support, serving the North American diagnostics and medical device market.
Whether you need development, analytical testing or regulatory support, our team is ready to help.